Articles

UK sight loss charities RP Fighting Blindness and Fight for Sight are joining forces to drive a project that will accelerate understanding of the genetic causes of inherited retinal dystrophies (IRD).

Patients with moderate and severe meibomian gland dysfunction (MGD) may benefit from topical loteprednol etabonate and eyelid scrubs with warm compresses, according to researchers in South Korea.

Travoprost monotherapy has demonstrated long-term 24-hour efficacy for the treatment of primary open-angle glaucoma (POAG).

Monovision correction and multifocal IOLs work well for correcting distance vision, with multifocal IOLs reducing the need for glasses but significantly increasing dysphotopsia for those who underwent implantation.

There is a correlation between functional cell loss in the retina and signs of dementia in people who have a genetic risk for frontotemporal dementia (FTD), according to researchers from the US.

Researchers at the University of Reading, UK, report that they have discovered a potential way of making eye drops more effective.

The US Food and Drug Administration (FDA) has approved a low-dose corticosteroid intravitreal implant for the treatment of diabetic macular oedema. (DME).

The Royal College of General Practitioners and the UK Vision Strategy initiative have produced a new guide, Sight Loss in Older People: The Essential Guide for General Practice.

Daily supplementation with selenium and/or vitamin E is unlikely to have a large preventive effect on the development of age-related cataracts, according to data from a recent study.

Monthly monitoring is no longer required for patients taking ranibizumab (Lucentis, Novartis) for a condition that is stable, due to a change in the drug's licence.

Cataract surgery is associated with a reduced risk of dementia later in life, researchers in Taiwan have found.

Anti-glaucoma preparations that do not contain benzalkonium chloride (BAK) were associated with a change in lubricant use in a study of 240 glaucoma patients, suggesting reduction in some ocular surface disease symptoms, according to research published online.

The European Society of Ophthalmology (SOE) and the American Academy of Ophthalmology (AAO) are holding a joint meeting 17 to 21 October at McCormick Place in Chicago, Illinois, USA. The meeting will be AAO's 118th annual meeting.

Non-damaging photothermal therapy using a pattern-scanning laser (PASCAL) guided by proprietary software is a safe and effective treatment for chronic central serous retinopathy (CSR), according to a recent study.

It's important to evaluate tear osmolarity during surgical planning to ensure that pre-surgical keratometry readings are not compromised by hyperosmolarity of the ocular surface.

Long-term observational data presented at the 2014 European Society of Retina Specialists (EURETINA) conference support the safety and efficacy profile of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab (Lucentis, Novartis) for the treatment of appropriate patients across its indications

Endoscopic cyclophotocoagulation (ECP) and phacoemulsification cataract extraction, when combined, result in greater reduction of IOP and need for IOP-lowering medications over 3 years compared with cataract extraction by itself.

The European Commission has extended marketing authorization for an intravitreal implant with 700 mcg of dexamethasone in an applicator (Ozurdex, Allergan) for the treatment of adults with visual impairment caused by diabetic macular oedema (DME) who have pseudophakia or whose condition is considered insufficiently responsive to or unsuitable for non-corticosteroid therapy.

A video goggle-based technology may help increase visual acuity (VA) in children with amblyopia.

An international study led by King's College London has identified genetic links to glaucoma.

Dr Omid Kermani discusses his pre-ESCRS diary, highlighting what he believes will be the best bits from the packed programme.

Optimal resistance to in vitro keratolysis by collagenase A can be achieved by collagen crosslinking the deepithelialized anterior corneal surface for 30 minutes, according to a recently published study.

Intracameral cefuroxime can help prevent endophthalmitis after cataract surgery and does so cost-effectively, according to Spanish researchers who conducted a systematic literature review.

Severe obstructive sleep apnoea (OSA) is an important risk factor for developing glaucoma and must be treated in those who have it to improve control of the eye disease, according to new research.

There have been few studies primarily concerned with the relative frequencies and clinical characteristics of cranial neuropathies in diabetic subjects. Here, Dr Stefanucci gives a synopsis of the clinical characteristics and risk factors.

We at OTEurope, wanted to look back over the last 10 years at what has changed over the years. In such a fast-paced industry, there have been monumental strides forward since the launch of this publication.

The international sight-saving charity Orbis has launched an appeal to help eliminate avoidable blindness in Ethiopia.

KalVista Pharmaceuticals has begun a Phase I trial of its plasma kallikrein inhibitor KVD001 for the treatment of diabetic macular oedema (DME).

Advanced DNA testing for congenital cataracts can quickly and accurately diagnose a number of rare diseases marked by childhood blindness, according to a study recently published online.

Researchers examining age-related changes in heparan sulphate (HS) quantity and composition in human Bruch's membrane (BrM) have discovered that the quantity greatly decreases with age, resulting in fewer binding sites for complement factor H (CFH) and affecting the ability of the 402H variant of CFH to bind BrM.